Posted on: 09 February, 2022
The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities.
The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 contribution, .....
Read more
Category: Research Excellence, World-leading technology
Posted on: 08 February, 2022
Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury.
Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers.
The program was trialled with staff from Aust.....
Read more
Category: Awards, Research Excellence
Posted on: 28 January, 2022
Congratulations to Kolling Institute researcher Dr Manasi Mittinty who has been selected for the Advanced Global Clinical Scholar Research training at Harvard Medical School.
Dr Mittinty is a medical trained researcher with the Pain Management and Research Centre and a University of Sydney lecturer. She has a keen interest in translation research and the connections between musculoskeletal conditio.....
Read more
Category: Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 20 December, 2021
Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk.
Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born early deal with ongoing health problems for the remainder of their lives.
The tea.....
Read more
Category: Research Excellence
Posted on: 20 December, 2021
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19.
Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country.
The study confirmed earlier conce.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 15 December, 2021
Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute.
Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Committee.
“Four.....
Read more
Category: Awards
Posted on: 06 December, 2021
Research conducted by a team from Kolling Institute has found that swallowing difficulties after a whiplash injury appear to be an under-recognised consequence of the injury.
The study investigated a group of 60 patients with low-grade whiplash, finding 50 per cent of patients reported swallowing problems within 12 months of their whiplash injury.
In 31 of these patients, there was a statistically .....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 26 November, 2021
In what will be disappointing news for many, a large-scale clinical trial has found platelet-rich plasma injections for those with osteoarthritis knee pain are no better than a placebo.
This type of injection has become an increasingly popular form of treatment for knee joint arthritis, despite its prohibitive cost at around $2,000 per injection.
Plasma from a patient’s own blood is injected direct.....
Read more
Category: Research Excellence
Posted on: 22 November, 2021
The Kolling’s new research plan has been confirmed marking an important milestone for the institute.
The plan details the implementation of the institute’s five-year strategy, and will ensure the Kolling is in the best position to deliver game-changing research.
Acting Executive Director Professor Jim Elliott has welcomed the development of the plan, saying a robust strategic framework will help sh.....
Read more
Category: Research Excellence
Posted on: 19 November, 2021
Congratulations to Kolling researcher Dr Jillian Eyles who’s been named one of the inaugural research translation fellows by Sydney Health Partners.
Facing tremendous competition from a large group of outstanding researchers, Jillian is one of just five people to have been awarded a fellowship, which means they’ll be able to dedicate a greater amount of their time to research.
Sydney Health Partner.....
Read more
Category: Awards